Skip to main content

Search form

You are here

Matthew Hartwig, MD

Director, Minimally Invasive Thoracic Surgery Fellowship
Associate Professor of Surgery
Division: 
Cardiovascular and Thoracic Surgery
Faculty Lab: 
Duke Ex-Vivo Organ Laboratory (DEVOL)
Program: 
Integrated Thoracic Surgery Residency Program
Minimally Invasive Thoracic Surgery Fellowship
Thoracic Transplant Surgery Fellowship
Traditional Cardiothoracic Surgery Residency
Office: DUMC 3863, Durham, NC 27710
Campus Mail: DUMC Box 3863 Med Ctr, Durham, NC 27710

Dr. Hartwig is a thoracic surgeon with a clinical focus in robotic assisted minimally invasive thoracic surgery for the treatment of diseases of the chest.  He serves as the Surgical Director of the Esophageal Center at Duke.  He is also the Director of the Minimally Invasive Thoracic Surgery Fellowship at Duke, while providing advanced instruction in robotic surgery to surgeons around the world. He also leads a successful program of clinical, basic and translational research in thoracic surgery and lung transplantation. He currently directs the Duke Ex Vivo Organ Laboratory (DEVOL), is the Chief of Lung Transplant Research, and is a faculty member at the Duke Clinical Research Institute (DCRI).

Dr. Hartwig has over 150 peer reviewed publications, received numerous awards, chaired many sessions at national and international meetings, serves regularly on NIH study sections, and is on the editorial board of many prominent journals. He has also personally mentored over pre-and post-doctoral trainees, many of whom are now engaged in their own successful research careers.

Education and Training

  • Chief Resident, Duke University, 2010 - 2011
  • Resident, Duke University, 2008 - 2010
  • Chief Resident, Duke University, 2007 - 2008
  • Senior Assistant Resident, Duke University, 2005 - 2007
  • Research Fellow, Duke University, 2003 - 2005
  • Junior Assistant Resident, Duke University, 2002 - 2003
  • Intern, Duke University, 2001 - 2002
  • M.D., Duke University, 2001

In the News

Selected Grants

Publications

Kesseli, Samuel J., Samantha E. Halpern, and Mathew G. Hartwig. “Commentary: Bruised and battered, but not broken-use of lung allografts from donors with chest trauma.” J Thorac Cardiovasc Surg 163, no. 5 (May 2022): 1735–36. https://doi.org/10.1016/j.jtcvs.2020.11.093.

Full Text

Jawitz, Oliver K., Vignesh Raman, David Becerra, Julie Doberne, Ashley Y. Choi, Samantha E. Halpern, Jacob A. Klapper, and Matthew G. Hartwig. “Lung Transplantation After Ex Vivo Lung Perfusion Early Outcomes From a US National Registry.” Ann Surg 275, no. 5 (May 1, 2022): 1006–12. https://doi.org/10.1097/SLA.0000000000004233.

Full Text

Halpern, Samantha E., Samuel J. Kesseli, and Matthew G. Hartwig. “Commentary: The jury is out-expanding eligibility for lung transplantation after hematopoietic stem cell transplantation.” J Thorac Cardiovasc Surg 163, no. 4 (April 2022): 1561–62. https://doi.org/10.1016/j.jtcvs.2020.11.103.

Full Text

Krischak, Madison K., Sandra Au, Samantha E. Halpern, Danae G. Olaso, Dimitrios Moris, Laurie D. Snyder, Andrew S. Barbas, John C. Haney, Jacob A. Klapper, and Matthew G. Hartwig. “Textbook surgical outcome in lung transplantation: Analysis of a US national registry.” Clin Transplant 36, no. 4 (April 2022): e14588. https://doi.org/10.1111/ctr.14588.

Full Text

Linden, Philip A., Mark I. Block, Yaron Perry, Henning A. Gaissert, Stephanie J. Worrell, Maria V. Grau-Sepulveda, Andrzej S. Kosinski, Oliver K. Jawitz, Matthew G. Hartwig, and Christopher W. Towe. “Risk of Each of the Five Lung Lobectomies: A Society of Thoracic Surgeons Database Analysis.” Ann Thorac Surg, March 24, 2022. https://doi.org/10.1016/j.athoracsur.2022.03.012.

Full Text

Gao, Qimeng, Matthew G. Hartwig, and Jamie L. Todd. “Bridging the translation gap in cytomegalovirus therapeutics through ex vivo lung perfusion: Opportunities and challenges.” J Heart Lung Transplant 41, no. 3 (March 2022): 298–99. https://doi.org/10.1016/j.healun.2021.11.018.

Full Text

Pages